VRK2
Basic information
Region (hg38): 2:57907629-58159920
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the VRK2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 34 | 35 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 13 | 22 | ||||
Total | 0 | 0 | 46 | 15 | 0 |
Variants in VRK2
This is a list of pathogenic ClinVar variants found in the VRK2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-58048847-A-G | not specified | Uncertain significance (Oct 03, 2023) | ||
2-58084112-A-G | not specified | Uncertain significance (Feb 26, 2024) | ||
2-58084881-G-A | not specified | Uncertain significance (Dec 14, 2022) | ||
2-58088354-G-C | not specified | Uncertain significance (Oct 26, 2021) | ||
2-58088363-A-G | not specified | Uncertain significance (Jun 01, 2023) | ||
2-58088415-A-G | not specified | Uncertain significance (Jun 23, 2023) | ||
2-58088442-G-A | not specified | Uncertain significance (Nov 01, 2022) | ||
2-58089649-A-C | not specified | Uncertain significance (Mar 28, 2024) | ||
2-58123117-A-G | not specified | Uncertain significance (Jan 29, 2024) | ||
2-58123144-A-G | not specified | Uncertain significance (Jan 10, 2023) | ||
2-58123192-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
2-58123198-T-C | not specified | Uncertain significance (Dec 22, 2023) | ||
2-58123206-A-G | not specified | Uncertain significance (Nov 01, 2022) | ||
2-58131820-G-A | not specified | Uncertain significance (Mar 29, 2023) | ||
2-58131827-C-G | not specified | Uncertain significance (Dec 21, 2021) | ||
2-58131855-C-T | not specified | Uncertain significance (Dec 17, 2023) | ||
2-58131856-G-A | not specified | Uncertain significance (Jan 12, 2024) | ||
2-58139666-G-A | not specified | Uncertain significance (Dec 17, 2023) | ||
2-58139726-A-G | not specified | Uncertain significance (Oct 25, 2022) | ||
2-58139755-C-T | not specified | Uncertain significance (Dec 22, 2023) | ||
2-58139792-A-G | not specified | Uncertain significance (Jan 24, 2024) | ||
2-58146317-T-C | not specified | Uncertain significance (May 11, 2022) | ||
2-58146365-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
2-58146381-A-T | not specified | Uncertain significance (Dec 17, 2023) | ||
2-58146397-A-G | not specified | Uncertain significance (Feb 26, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
VRK2 | protein_coding | protein_coding | ENST00000435505 | 12 | 252270 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.57e-11 | 0.572 | 125647 | 0 | 100 | 125747 | 0.000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.949 | 300 | 257 | 1.17 | 0.0000122 | 3329 |
Missense in Polyphen | 97 | 89.337 | 1.0858 | 1167 | ||
Synonymous | 0.0845 | 89 | 90.0 | 0.989 | 0.00000449 | 901 |
Loss of Function | 1.39 | 21 | 29.1 | 0.721 | 0.00000141 | 377 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000711 | 0.000710 |
Ashkenazi Jewish | 0.0000995 | 0.0000992 |
East Asian | 0.000225 | 0.000217 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000534 | 0.000528 |
Middle Eastern | 0.000225 | 0.000217 |
South Asian | 0.000436 | 0.000425 |
Other | 0.000663 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Serine/threonine kinase that regulates several signal transduction pathways. Isoform 1 modulates the stress response to hypoxia and cytokines, such as interleukin-1 beta (IL1B) and this is dependent on its interaction with MAPK8IP1, which assembles mitogen-activated protein kinase (MAPK) complexes. Inhibition of signal transmission mediated by the assembly of MAPK8IP1-MAPK complexes reduces JNK phosphorylation and JUN-dependent transcription. Phosphorylates 'Thr-18' of p53/TP53, histone H3, and may also phosphorylate MAPK8IP1. Phosphorylates BANF1 and disrupts its ability to bind DNA and reduces its binding to LEM domain-containing proteins. Downregulates the transactivation of transcription induced by ERBB2, HRAS, BRAF, and MEK1. Blocks the phosphorylation of ERK in response to ERBB2 and HRAS. Can also phosphorylate the following substrates that are commonly used to establish in vitro kinase activity: casein, MBP and histone H2B, but it is not sure that this is physiologically relevant.;
- Pathway
- Clearance of Nuclear Envelope Membranes from Chromatin;Nuclear Envelope Breakdown;Mitotic Prophase;Initiation of Nuclear Envelope Reformation;Nuclear Envelope Reassembly;Mitotic Anaphase;Mitotic Metaphase and Anaphase;M Phase;Cell Cycle;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.0962
Intolerance Scores
- loftool
- 0.999
- rvis_EVS
- 0.07
- rvis_percentile_EVS
- 58.96
Haploinsufficiency Scores
- pHI
- 0.133
- hipred
- N
- hipred_score
- 0.336
- ghis
- 0.575
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.951
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Vrk2
- Phenotype
Gene ontology
- Biological process
- protein phosphorylation;viral process;peptidyl-serine phosphorylation;peptidyl-threonine phosphorylation;cellular response to oxidative stress;regulation of MAPK cascade;protein autophosphorylation;regulation of interleukin-1-mediated signaling pathway
- Cellular component
- nucleus;cytoplasm;endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane;mitochondrial membrane;protein-containing complex
- Molecular function
- protein serine/threonine kinase activity;protein binding;ATP binding;protein kinase binding;protein domain specific binding